Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery

Area of Science:

• Ophthalmology
• Surgical Innovation
• Pharmacology

Background:

• Glaucoma is an optic neuropathy causing vision loss, managed by lowering intraocular pressure (IOP).
• Filtering surgery is an option when less invasive methods fail, but scar formation can impede filtration and reduce success.
• Current antifibrotic strategies have limitations due to the complex fibrotic process and drug toxicity.

Purpose of the Study:

• To review available and potential pharmacological treatments for modulating scar tissue after glaucoma surgery.
• To analyze the efficacy and limitations of current antifibrotic agents.
• To explore novel therapeutic strategies for improving glaucoma surgery outcomes.

Main Methods:

• Literature review of pharmacological interventions targeting the fibrotic process in glaucoma surgery.
• Analysis of evidence on non-steroidal anti-inflammatory drugs (NSAIDs), mitomycin, and 5-fluorouracil.
• Investigation into emerging therapeutic targets for scar modulation.

Main Results:

• NSAIDs, mitomycin, and 5-fluorouracil are primary agents for scar modulation, but their long-term efficacy is limited.
• The complexity of fibrosis and drug-related toxicities contribute to surgical failure.
• Existing strategies face challenges in effectively controlling excessive scarring.

Conclusions:

• Current antifibrotic treatments for glaucoma surgery have significant limitations.
• Developing multi-target approaches is crucial to overcome the complexity of the fibrotic process.
• Novel strategies are needed to enhance the long-term success of glaucoma filtering surgery.